COMMUNIQUÉS West-GlobeNewswire

TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc.
08/05/2026
FREDERICK, Md., May 08, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT [...]
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
08/05/2026
REGULATED INFORMATION May 8, 2026, 10:05pm CET / 4:05pm ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the annual [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
WESTLAKE VILLAGE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
FDA Grants Seventh Approval under the National Priority Voucher Pilot Program
08/05/2026
White Oak, Md., May 08, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued an approval for Bizengri (zenocutuzumab-zbco), a drug that treats NRG1 fusion-positive cholangiocarcinoma, an ultra- [...]
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
08/05/2026
MIAMI, May 08, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related [...]
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
08/05/2026
VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab positive, anti-MuSK-Ab positive, anti-LRP4-Ab positive, and triple seronegative [...]
Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims
08/05/2026
How Shiny Smile Veneers' At-Home Snap-On Custom Fit System, Dr. Dean's Dentist-Designed Process, FDA-Approved Material Claims, 60-Day Guarantee Terms, and Consumer Complaints and Reviews Stack Up in 2026 Richardson, TX [...]
More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October
08/05/2026
Two-Day Premium Experience at the James L. Knight Center Headlined by Human Biologist Gary Brecka and 2x Mr. Olympia Derek Lunsford, with Title Sponsor AllCore360° MIAMI, Fl., May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program
08/05/2026
Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
Major Shareholder Announcement
08/05/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; May 8, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Her Bodhi Claims Evaluated: Meno & Hormonal Support for Women by HerBodhi Under Investigation
08/05/2026
Her Bodhi Meno Ingredient Research: KSM-66 Ashwagandha, Black Cohosh, and Red Clover Ingredients, Side Effects, Pricing, and Refund Policy for Menopause Support in 2026 Los Angeles, CA, May 08, 2026 (GLOBE NEWSWIRE) -- [...]
Erdem Health Group Enters Türkiye’s TURQUALITY Program
08/05/2026
The recognition supports Istanbul-based healthcare group’s international brand strategy and reinforces its quality-focused growth in health tourism Erdem Health Group has been accepted into TURQUALITY®, Türkiye’s state- [...]
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
08/05/2026
SOUTH SAN FRANCISCO, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the closing of an underwritten public offering of 11,338,028 shares of its common stock, including [...]
MIMEDX Announces Launch of G4Derm® Plus
08/05/2026
Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company’s Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. ( [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026
BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
08/05/2026
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will [...]
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
08/05/2026
- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive disease and high CD47 expression experienced durable responses to this [...]
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases
08/05/2026
Plenary session at AANS underscores REYOBIQ’s potential as a differentiated targeted radiotherapeutic platform for CNS cancers HOUSTON, Texas, May 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“ [...]
Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026
08/05/2026
DURHAM, N.C., May 08, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]

Pages